Estradiol percutaneous administration preparations
CA 2066249 C · Owner: Nakagawa, Akira · Inventors: Shinmura, Miyuki; Nakagawa, Akira; Hirano, Munehiko
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
1. An estradiol percutaneous administration preparation comprising:, (1) a (A-B) nX or (A-B) n-A type elastomer wherein A is substantially monovinylsubstituted aromatic compound polymer block B is, substantially a conjugated diolefin copolymer block n, is an integer of 3 - 7, and X is a residue derived from a polyfunctional compound combined with n of polymer chain (A-B). (2) crotamiton and (3) a super assorbent polymer, the, preparation further comprising estradiol as the medicinal ingredient and exhibiting sufficient medicinal efficacy without causing rubefaction rashes, and the like.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed April 26, 1991 and granted December 16, 1997. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended April 26, 2011.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by April 26, 2013.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.